e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hypoxia inducible factor-1? in human emphysema lung tissue
Yasuo M., Mizuno S., Kraskauskas D., Bogaard H.J., Natarajan R., Cool C.D., Zamora M., Voelkel N.F.
Source:
Eur Respir J 2011; 37: 775-783
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Yasuo M., Mizuno S., Kraskauskas D., Bogaard H.J., Natarajan R., Cool C.D., Zamora M., Voelkel N.F.. Hypoxia inducible factor-1? in human emphysema lung tissue. Eur Respir J 2011; 37: 775-783
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Pulmonary vascular involvement in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 28S-32S
Year: 2003
Cytokines in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: 50S-59S
Year: 2001
Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis
Source: Eur Respir J 2006; 27: 957-963
Year: 2006
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 653s
Year: 2006
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
Bioavailability of vascular endothelial growth factor (VEGF)? A role in pulmonary fibrosis?
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Morphometric study of hypoxia inducible factor-1α-vascular endothelial growth factor (HIF-1α-VEGF) axis in patients with idiopathic pulmonary fibrosis with the use of tissue microarrays
Source: Eur Respir J 2006; 28: Suppl. 50, 338s
Year: 2006
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis
Source: Eur Respir J 2006; 28: 533-541
Year: 2006
Effect of cyclooxygenase-2 inhibition on lung inflammation and hypoxia-inducible factor-1 signalling in COPD model
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
The effect of mtTFA methylation in the pathogenesis of pulmonary vascular endothelial cell apoptosis of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Changes of alveolar oxygen tension in chronic obstructive pulmonary disease (COPD) and effect of variable oxygen tension on hypoxia inducible factor (HIF)-1alpha system of alveolar epithelial cells
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Reduced pulmonary vascular response to hypoxia is associated with endothelial dysfunction in chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 173s
Year: 2001
Placenta growth factor (PlGF) triggers small airway remodeling (SAR) in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Year: 2017
Increased binding activity of hypoxia inducible factor (HIF)-1α to vascular endothelial growth factor (VEGF) promoter region mediates enhanced vascular permeability in the lung of cystic fibrosis (CF) patients
Source: Eur Respir J 2003; 22: Suppl. 45, 173s
Year: 2003
Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma
Source: Eur Respir J 2003; 21: 804-809
Year: 2003
Role of vascular endotelial growth factor polymorphisms in interstitial lung disease
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013
Dual mechanism of platelet-derived growth factor (PDGF)-receptor: Contribution of vascular response to the pathogenesis of pulmonary hypertension (PH)
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Epidermal growth factor in the lungs of infants developing chronic lung disease
Source: Eur Respir J 2001; 18: 796-800
Year: 2001
Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 574s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept